These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25512164)

  • 1. Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.
    Zakeri R; Burnett JC; Sangaralingham SJ
    Clin Chim Acta; 2015 Mar; 443():108-13. PubMed ID: 25512164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging.
    Sangaralingham SJ; Heublein DM; Grande JP; Cataliotti A; Rule AD; McKie PM; Martin FL; Burnett JC
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F943-52. PubMed ID: 21865266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
    Kalra PR; Clague JR; Coats AJ; Anker SD; Poole-Wilson PA; Struthers AD
    Clin Sci (Lond); 2009 Oct; 118(1):71-7. PubMed ID: 19450232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type natriuretic peptide: a new cardiac mediator.
    Del Ry S
    Peptides; 2013 Feb; 40():93-8. PubMed ID: 23262354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis.
    Hu P; Wang J; Hu B; Lu L; Xuan Q; Qin YH
    Peptides; 2012 Sep; 37(1):98-105. PubMed ID: 22743139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type natriuretic peptide and heart failure.
    Del Ry S; Passino C; Emdin M; Giannessi D
    Pharmacol Res; 2006 Nov; 54(5):326-33. PubMed ID: 16904335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
    Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P
    Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target organ cross talk in cardiorenal syndrome: animal models.
    Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.
    Palazzuoli A; Masson S; Ronco C; Maisel A
    Heart Fail Rev; 2014 Mar; 19(2):267-84. PubMed ID: 23563622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
    Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D
    Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity.
    Cabiati M; Sabatino L; Caruso R; Verde A; Caselli C; Prescimone T; Giannessi D; Del Ry S
    Peptides; 2013 Sep; 47():110-4. PubMed ID: 23911666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Biomarkers of Heart Failure.
    Savic-Radojevic A; Pljesa-Ercegovac M; Matic M; Simic D; Radovanovic S; Simic T
    Adv Clin Chem; 2017; 79():93-152. PubMed ID: 28212715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Cardiorenal Syndromes.
    Fu S; Zhao S; Ye P; Luo L
    Biomed Res Int; 2018; 2018():9617363. PubMed ID: 29693019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort.
    Brouwers FP; van Gilst WH; Damman K; van den Berg MP; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van der Harst P; de Boer RA
    Circ Heart Fail; 2014 Sep; 7(5):723-31. PubMed ID: 25057112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.